← Back to patent-cliff list
富马酸托特罗定
Tier C — Watch / tradeTolterodine Fumarate
辉瑞
Originator
2005
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：mAChRs
Indications (approved)：膀胱过度活动症
Regional status
US
-
EU
-
China
批准上市
2005-12-09
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tolterodine Fumarate?
Approved indications include: 膀胱过度活动症.
When does the Tolterodine Fumarate patent expire?
No public expiry year is available for Tolterodine Fumarate yet; this page updates once verified.
How do I get a quote for Tolterodine Fumarate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24